Contact Uscontact

Parc Euromédecine, Cap Gamma
1682 Rue de la Valsière - CS17383
34189 Montpellier cedex 4 - FRANCE

Office +33 (0)4 67 727 670
FAX : +33 (0)4 67 727 679


3 oncology-focused projects, including novel targeted therapies (molecules and antibodies), under development and potentially available for licensing or collaboration.
» Read more ...


04/25/13 : OriBase Pharma is entitled to taxes return for investment

Thanks to a first round of fund raising realized successfully ( 1 500 000€), involving 52 investors, we were able...
» Read more ...

Vision - Mission


OriBase Pharma vision is to develop First-In-Class or Best-In-Class molecules against kinases involved in aggressive cancers with high unmet medical need.

OriBase Pharma mission is to leverage its platform and cancer biology expertise to obtain patentable drug candidates. Thanks to its HitFastDiscovery® technology platform, OriBase Pharma is able to accelerate the identification process of bioactive molecules and generate optimized leads that are in vivo active and patentable in less than 18 months.